EGFR and breast cancer: A similar approach was used to investigate the regulation and role of EGFR in luminal BC[89] where the knockdown of TFAP2C has induced decreased expression of EGFR in a panel of this tumor and, consistently, the EGFR gene has resulted by ChIP-seq to be a TFAP2C target.